BIO.BE SA
5.4 FTEThe score of BIO.BE shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -57 % Total assets -39 % Headcount (avg FTE) -75 %
Accounts of the company itself (not consolidated).
The full file covers 18 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
BIO.BE's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 Jun 2026
- Year ended 31 Dec 2024filed on 03 Jul 2025
- Year ended 31 Dec 2023filed on 08 Jul 2024
- Year ended 31 Dec 2022filed on 26 Jun 2023
- Year ended 31 Dec 2021filed on 22 Jun 2022
BIO.BE's financial analysis
- Solvency47.9%sector median: 65.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of BIO.BE
BIO.BE's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0861.738.595
- VAT number
- BE0861738595
- Peppol
- Registered · 0208:0861738595 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 20 Nov 2003
- Registered office
- 6041 Charleroi
- Size
- Micro · 5.4 FTE
- Latest accounts
- 2025 · filed on 19 Jun 2026
- Activity
- Diagnostic imaging services and medical laboratory activities (NACE 86910)
BIO.BE (SA) has been based in Charleroi since 2003, active in: diagnostic imaging services and medical laboratory activities. For 2025, it reports a net loss of 244,508 € and equity of €1.46m; its revenue is not published. With 5.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 47.9%, below the median of its sector (65.6%).
Companies similar to BIO.BE
Companies in the same business, of comparable size and area, outside its group.
- Fertiga Research and experimental development on natural sciences and engineering Lede · balance sheet €2.06m
- ECG Labs Activities of holding companies Lummen · balance sheet €2.64m
- InnoSer België Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet €2.12m
- Aligos Belgium Research and experimental development on natural sciences and engineering Leuven · balance sheet €1.82m
- OncoDNA Diagnostic imaging services and medical laboratory activities Charleroi · balance sheet €5.27m
- Radiologie DRS.VAN Meerbeeck Other education n.e.c. Bornem · balance sheet 843,721 €
- Abscint Research and experimental development on natural sciences and engineering Liège · balance sheet €6.85m
- Syneos Health Belgium Research and experimental development on natural sciences and engineering Brussels · balance sheet €8.53m
Frequently asked questions about BIO.BE
What is the revenue of BIO.BE?
BIO.BE files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of BIO.BE?
In Belgium, the VAT number is the company number prefixed with BE: BE0861738595 for BIO.BE, if the company is VAT-registered. Its company number (CBE) is 0861.738.595.
Where is the registered office of BIO.BE?
According to the CBE register, the registered office of BIO.BE is in 6041 Charleroi.
What is the equity of BIO.BE?
At the close of the 2025 financial year, the equity of BIO.BE amounts to 1,455,504 €, a solvency of 47.9% of total assets.
How many people work at BIO.BE?
5.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages BIO.BE?
The register lists 6 active mandates at BIO.BE. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of BIO.BE
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →